United States· US:58151-065_164394b3-d7ba-4bbf-b64b-e2dd15735ea8
Caduet
A dihydropyridine derivatives product containing amlodipine and atorvastatin, registered in United States by Viatris Specialty LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- amlodipine and atorvastatin
- Manufacturer
- Viatris Specialty LLC
- Country
- United States (US)
- ATC code
- C08CA
- ATC class
- Dihydropyridine derivatives
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc11581510659330 TABLET, FILM COATED in 1 BOTTLE (58151-065-93)
Regulatory notes
Same class
Other records under C08CA
Dihydropyridine derivatives, as other registers publish it.
- United StatesAmlodipine and Benazepril HydrochlorideHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesAmlodipine and Benazepril HydrochlorideHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesAmlodipine and Benazepril HydrochlorideHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesAmlodipine and Benazepril HydrochlorideHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- United StatesCaduetViatris Specialty LLC
- United StatesCaduetViatris Specialty LLC
- United StatesCaduetViatris Specialty LLC
- United StatesCaduetViatris Specialty LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/65d0237d-bbcc-4a71-8baa-1e78be4cf735 GET /v1/drugs/65d0237d-bbcc-4a71-8baa-1e78be4cf735?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "864V2Q084H",
"rxcui": "104416",
"inchikey": "ZPBWCRDSRKPIDG-UHFFFAOYSA-N",
"display_name": "AMLODIPINE BESYLATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6": {
"match": "brand_token",
"title": "CADUET (AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM) TABLET, FILM COATED CADUET (AMLODIPINE AND ATORVASTATIN) TABLET, FILM COATED [PFIZER LABORATORIES DIV PFIZER INC]",
"spl_version": "51",
"published_date": "2026-05-25"
}
},
"productid": "58151-065_164394b3-d7ba-4bbf-b64b-e2dd15735ea8",
"productndc": "58151-065",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "021540",
"products": [
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 5MG BASE;EQ 10MG BASE",
"product_no": "001",
"approval_date": "Jan 30, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 5MG BASE;EQ 20MG BASE",
"product_no": "002",
"approval_date": "Jan 30, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 5MG BASE;EQ 40MG BASE",
"product_no": "003",
"approval_date": "Jan 30, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 5MG BASE;EQ 80MG BASE",
"product_no": "004",
"approval_date": "Jan 30, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 10MG BASE;EQ 10MG BASE",
"product_no": "005",
"approval_date": "Jan 30, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 10MG BASE;EQ 20MG BASE",
"product_no": "006",
"approval_date": "Jan 30, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 10MG BASE;EQ 40MG BASE",
"product_no": "007",
"approval_date": "Jan 30, 2004"
},
{
"rs": true,
"rld": true,
"te_code": "AB",
"strength": "EQ 10MG BASE;EQ 80MG BASE",
"product_no": "008",
"approval_date": "Jan 30, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 2.5MG BASE;EQ 10MG BASE",
"product_no": "009",
"approval_date": "Jul 29, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 2.5MG BASE;EQ 20MG BASE",
"product_no": "010",
"approval_date": "Jul 29, 2004"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 2.5MG BASE;EQ 40MG BASE",
"product_no": "011",
"approval_date": "Jul 29, 2004"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE",
"shortage_reason": "Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet",
"shortage_status": "current",
"proprietary_name": "Caduet",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "NDA021540",
"marketing_category": "NDA",
"nonproprietary_name": "amlodipine and atorvastatin",
"start_marketing_date": "20260225",
"active_numerator_strength": "5; 20"
}See everything about amlodipine and atorvastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.